Omkar Pharmachem Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Omkar Pharmachem Ltd. on BSE

Load latest

11 Apr 2025

Company Update

Omkar Pharmachem Ltd - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Dear Sir, Please find certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2025.

pdf

Omkar Pharmachem Ltd.

27 Mar 2025

SAST

Omkar Pharmachem Ltd - 532167 - Closure of Trading Window

BSE India

Dear Sir, Pursuant to SEBI (Prohibition of Insider Trading Regulations), 2015 as amended and in compliance with terms of Code of Conduct of the Company, please note that the Trading window for dealing in shares of the Company will remain closed for the designated person and their immediate relatives from Tuesday, 1st April, 2025 till the completionof 48 hours after the date of declaration of Audited financial results of the Company for the quarter and year ended on 31.03.2025.

pdf

Omkar Pharmachem Ltd.

15 Feb 2025

Company Update

OMKAR PHARMACHEM LTD. - 532167 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Dear Sir, Please find attached the newspaper advertisement for the Unaudited Financial Results for the Quarter and Nine months ended 31 December 2024.

pdf

Omkar Pharmachem Ltd.

14 Feb 2025

Corp. Note

OMKAR PHARMACHEM LTD. - 532167 - Integrated Filing (Financial)

BSE India

Dear Sir, Please find attached Integrated Filing- Financials for Quarter ended December 31, 2024.

pdf

Omkar Pharmachem Ltd.

14 Feb 2025

Result

OMKAR PHARMACHEM LTD. - 532167 - Financial Results For December 31, 2024

BSE India

Dear Sir, Please find attached herewith Unaudited Financial Results for the Quarter ended 31 December 2024.

pdf

Omkar Pharmachem Ltd.

14 Feb 2025

Board Meeting

OMKAR PHARMACHEM LTD. - 532167 - Board Meeting Outcome for The Board Meeting Held On 14Th …

BSE India

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 14th February, 2025 has considered and approved the unaudited Financial Results of the Companyand Limited Review Report for the Quarter ended on 31.12.2024.

pdf

Omkar Pharmachem Ltd.

06 Feb 2025

Board Meeting

OMKAR PHARMACHEM LTD. - 532167 - Board Meeting Intimation for Board Meeting Intimation For Consideration And …

BSE India

OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve OMKAR PHARMACHEM LTD. has informed BSE that the meeting of the Board of Directors of the Company has been scheduled on 14/02/2025 ,inter alia, to consider and approve the unaudited financial results of the company for Quarter ended on 31st December 2024.

pdf

Omkar Pharmachem Ltd.

18 Jan 2025

Company Update

OMKAR PHARMACHEM LTD. - 532167 - Appointment of Company Secretary and Compliance Officer

BSE India

Dear Sir/Madam, Pursuant to Regulation 30 and other applicable provisions of the Listing Regulations, we hereby inform that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held today viz. Saturday, January 18th, 2025, approved the appointment of Mr. Pankaj Mahadeo Singh as Company Secretary and Compliance Officer w.e.f. January 18th, 2025.

pdf